← Back to Search

Other

Implementation Strategies for Medication-Assisted Treatment for Opioid Addiction (SITT-MAT Trial)

N/A
Waitlist Available
Led By Mark McGovern, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Residential (detoxification or rehabilitation) or outpatient (intensive outpatient or outpatient) levels of care
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up months 1,7,14,24,34,46
Awards & highlights

SITT-MAT Trial Summary

This trial will help researchers understand how to best help addiction treatment programs implement new treatments, like medication-assisted treatment for opioid use disorder.

Who is the study for?
This trial is for addiction treatment programs in Washington State that handle opioid use disorder but are not opioid treatment programs. It includes residential detox or rehab, outpatient services, primary care clinics like FQHCs and CHCs.Check my eligibility
What is being tested?
The study tests a stagewise approach to implementing medications for opioid use disorder (MOUD) across various addiction programs. Strategies include Enhanced Monitoring and Feedback, NIATx/MAT Academy, and randomization between two types of facilitation methods with goals of reaching specific implementation targets.See study design
What are the potential side effects?
Since this trial focuses on the implementation strategies rather than direct patient interventions, it does not directly address medication side effects. However, MOUD can have side effects such as nausea, drowsiness, constipation which are not specifically studied here.

SITT-MAT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently in a detox, rehab, or outpatient care program.

SITT-MAT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~months 1,7,14,24,34,46
This trial's timeline: 3 weeks for screening, Varies for treatment, and months 1,7,14,24,34,46 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adoption
Effectiveness
Implementation - Integrating Medications for Addiction Treatment (IMAT) Index
+1 more
Other outcome measures
Contextual determinants
Cost of implementation
Engagement in implementation
+3 more

SITT-MAT Trial Design

5Treatment groups
Experimental Treatment
Group I: Path 5Experimental Treatment4 Interventions
Enhanced Monitoring and Feedback + NIATx/MAT Academy + NIATx Internal Facilitation + NIATx External Facilitation
Group II: Path 4Experimental Treatment3 Interventions
Enhanced Monitoring and Feedback + NIATx/MAT Academy + NIATx Internal Facilitation
Group III: Path 3Experimental Treatment3 Interventions
Enhanced Monitoring and Feedback + NIATx/MAT Academy + NIATx External Facilitation
Group IV: Path 2Experimental Treatment2 Interventions
Enhanced Monitoring and Feedback + NIATx/MAT Academy
Group V: Path 1Experimental Treatment1 Intervention
Enhanced Monitoring and Feedback

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,393 Previous Clinical Trials
17,341,145 Total Patients Enrolled
1 Trials studying Opioid Addiction
500 Patients Enrolled for Opioid Addiction
University of Wisconsin, MadisonOTHER
1,183 Previous Clinical Trials
3,167,507 Total Patients Enrolled
Washington State Health Care AuthorityUNKNOWN

Media Library

Opioid Addiction Research Study Groups: Path 2, Path 3, Path 5, Path 4, Path 1
Enhanced Monitoring and Feedback (EMF) (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05343793 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the maximum capacity for enrollees in this experiment?

"Affirmative. Clinicaltrials.gov indicates that this medical study, initially posted on March 14th 2022, is still enrolling patients. Specifically, 64 participants are needed from one location and the details were most recently revised on August 24th 2022."

Answered by AI

Are recruitment efforts currently underway for this experiment?

"Per clinicaltrials.gov, enrollment for this medical trial is currently open. It was first published on March 14th and the most recent update was posted August 24th of 2022."

Answered by AI

Are septuagenarians eligible to participate in this experiment?

"According to this medical trial's eligibility rules, interested parties must be between the age of 18 and 99."

Answered by AI

Am I eligible to be a participant in this research study?

"64 men and women aged 18-99 with opioid addiction are currently being recruited for this research effort. To be eligible, participants must have an affiliation to a Washington state treatment program as well as access to primary care clinics like FQHCs or CHCs."

Answered by AI

Who else is applying?

What site did they apply to?
Washington State Healthcare Authority
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I have tried to get clean so many times and failed every time. I want to try something different.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)
Mark McGovern 2022. "Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05343793.
All > Addiction
~24 spots leftby Jun 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top